ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,969.34
0.35%
US Tech 100
20,266.40
0.33%
다우존스 지수
44,296.51
0.97%
Bitcoin
98,334.02
0.56%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 유럽
  5. EU

  6. Prosus NV (PRX) 시세

Prosus NV

Prosus NV (PRX)

Prodigy Gold NL
37.97
-0.135
(-0.35%)
마감 24 11월 1:30AM
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
37.97
매수가
37.88
매도가
38.20
거래량
2,464,070
37.60 일간 변동폭 38.08
23.755 52주 범위 41.78
market_cap
108.956B
전일 종가
38.105
개장가
37.60
최근 거래 시간
719
@
37.97
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
2,900,163
발행 주식
2,869,538,000
배당수익률
-
주가수익률
16.49
주당순이익(EPS)
2.3
매출
6.22B
순이익
6.61B

Prosus NV 정보

섹터
Internet Service Provider
산업
Internet Service Provider
웹사이트
www.prosus.com
본부
Amsterdam, North Holland, Nld
설립됨
-
Prosus NV is listed in the Internet Service Provider sector of the 유로넥스트 (Euronext) with ticker PRX. The last closing price for Prosus NV was 38.11 €. Over the last year, Prosus NV shares have traded in a share price range of 23.755 € to 41.78 €.

Prosus NV currently has 2,869,538,000 shares in issue. The market capitalisation of Prosus NV is 109.34 € billion. Prosus NV has a price to earnings ratio (PE ratio) of 16.49.

PRX 최신 뉴스

추가 뉴스

Par Pharmaceutical Companies to Report Fourth Quarter and Full Year 2009 Results on February 24, 2010

WOODCLIFF LAKE, N.J., Feb. 2 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) announced today that it will host a conference call and live webcast on Wednesday, February...

03 2월 2010
PR Newswire (US)

MonoSol Rx and Strativa Pharmaceuticals Extend Strategic Relationship

Option to collaborate on three new products Relationship built on successful development of ondansetron oral soluble film currently under FDA review WARREN, N.J., Jan. 5 /PRNewswire/ -- MonoSol...

05 1월 2010
PR Newswire (US)

Par Pharmaceutical Receives Final Approval to Market Generic Ultram(R) ER

Par to Begin Shipping Tramadol ER Immediately WOODCLIFF LAKE, N.J., Nov. 16 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) today announced that it has received final...

16 11월 2009
PR Newswire (US)

Par Pharmaceutical Reports EPS of $0.76 for Third Quarter 2009

Achieves Record Quarterly Gross Margin of $92 Million WOODCLIFF LAKE, N.J., Nov. 6 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) today reported results for the third...

06 11월 2009
PR Newswire (US)

Par Pharmaceutical Receives Final Approval To Market Generic Starlix(R)

Par to Begin Shipping Nateglinide Immediately WOODCLIFF LAKE, N.J., Sept. 10 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) today announced that it has received final...

11 9월 2009
PR Newswire (US)

Par Pharmaceutical Reports EPS of $0.71 for Second Quarter 2009

Brand & Generic Business Units Drive Strong Earnings WOODCLIFF LAKE, N.J., Aug. 4 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) today reported results for the second...

04 8월 2009
PR Newswire (US)

Par Pharmaceutical to Host Second Quarter 2009 Earnings Conference Call on August 4 at 9:00 am

WOODCLIFF LAKE, N.J., July 15 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE:PRX) announced today that it will host a conference call and live webcast on Tuesday, August 4...

15 7월 2009
PR Newswire (US)

MonoSol Rx and Strativa Pharmaceuticals Submit New Drug Application for Ondansetron Orally Dissolving Film Strip

WARREN, N.J., April 9 /PRNewswire/ -- MonoSol Rx, the developers of PharmFilm(R) technology and a drug delivery company specializing in dissolving thin film pharmaceutical products, and Strativa...

09 4월 2009
PR Newswire (US)

MonoSol Rx Successfully Completes Pivotal Bioequivalence Studies for Ondansetron Thin Film NDA

Expects to File NDA with FDA in Early to Mid-2009 WARREN, N.J., Dec. 2 /PRNewswire/ -- MonoSol Rx, the developers of PharmFilm(R) technology and a drug delivery company specializing in...

02 12월 2008
PR Newswire (US)

/C O R R E C T I O N -- Par Pharmaceutical Companies, Inc./

In the news release, Patrick G. LePore Elected to Board of Directors of Par Pharmaceutical Companies, Inc., issued earlier today by Par Pharmaceutical Companies, Inc. over PR Newswire, we are...

23 5월 2006
PR Newswire (US)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.1450.38334434897637.82538.8137.57245041037.95303346DE
4-1.03-2.641025641033940.30537.5278487138.69662692DE
124.7114.1611545433.2641.7832.02290016337.7196992DE
263.128.9526542324234.8541.7829.945273145035.38979239DE
527.8325.978765759830.1441.7823.755296220432.08625044DE
156-39.6-51.050663916577.5779.7523.755259127647.42262697DE
260-24.13-38.856682769762.1109.823.755232816856.74094248DE

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
MLAAHAmatheon Agri Holding NV
0.02 €
(100.00%)
5k
GNROGeNeuro SA
0.0768 €
(25.49%)
200
BIDSGascogne DS
0.005 €
(25.00%)
150.51k
ALSAFSAFE
0.11 €
(23.73%)
39.98k
ALKKOKKO International SA
0.112 €
(21.21%)
4.13M
ALIMOGroupimo
0.189 €
(-40.94%)
392
MLUMGUmalis Group
1.30 €
(-31.22%)
1.71k
MLNMAMiguet Et Associes
0.075 €
(-24.62%)
1.72k
MLSEQSequa Petroleum NV
0.008 €
(-20.00%)
23k
VACBSPierre & Vacances
0.05 €
(-15.25%)
35.99k
BCPBanco Comercial Portugues SA
0.4446 €
(-0.49%)
69.24M
ALNEVNeovacs
0.0002 €
(0.00%)
41.4M
ALCYBCybergun
0.0001 €
(0.00%)
30.32M
INGAING Groep NV
14.652 €
(-1.16%)
14.06M
ACACredit Agricole SA
13.05 €
(-1.66%)
8.06M

토론

전체 피드 보기
crescentmotor crescentmotor 7 분 전
Those continued lower gas prices will help with prices at the store.

Yes, but there will be offsets if the FED keeps lowering interest rates and pumping up the money supply by printing fiat currency to continue buying back bonds. That would lead to both more devaluation of the $ and
AVXL
rosemountbomber rosemountbomber 10 분 전
And, at my advanced age, that is why I still change my own oil.  
AMRN
uber darthium uber darthium 11 분 전
GlobalDelCrappo

Noted and Correct
GDSI
axelvento axelvento 23 분 전
Johns Hopkins surgeon Makary is Trump’s pick to lead FDA "pro-vaccine"

https://www.healthcaredive.com/news/trump-fda-martin-makary-surgeon-nominate/733829/
MRNA
TomD2046 TomD2046 24 분 전
Hahalolo invest site maintenance got updated to November 30th for completion... https://invest.hahalolo.com/
FBEC
shajandr shajandr 24 분 전
https://investorshub.advfn.com/uimage/uploads/2013/10/2/hqxjrthat-sounds-fascinating-please-go-on-thumb.jpg
crescentmotor crescentmotor 26 분 전
Large import duties will drive up inflation on goods and expulsion of workers who do mostly farm work and construction will drive up inflation on food and housing.

Further, tariffs will make the U.S. even less competitive in the manufacturing arena with China, which is already making
AVXL
Golfbum22 Golfbum22 26 분 전
Ask the lawyer

Rule of law guy

Interested also

Thx
FMCC
The ELTP King The ELTP King 30 분 전
Notice how Nasrat was questioning whether or not we'd have enough money for the API for the three newly acquired drugs?

This didn't include the MASSIVE 4.3 BILLION DOLLAR DRUG we just received approval on.

Keep your eyes peeled for a HUGE loan in the form of an 8-K with
API
CanItBThisEZ2Make CanItBThisEZ2Make 33 분 전
BEST SELLERS RANK (BSR) IS 327 46 Estimated Sold on Amazon Since OCT 1 - 4TH Quarter 2024
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value Dec
SRMX
rossirace9s rossirace9s 34 분 전
Ohhhh that's right. It changed names to Algernon Pharmaceuticals and now has a $1.57 million market cap with average 10 day volume of 3.28k shares with the same players. Sell this heaping pile before it's too late.
BLOZF
The ELTP King The ELTP King 38 분 전
Question: "Will Elite have enough working capital to buy all the API needed when the three new drug repurchases are launched? Or do we have to get more loans?"

Nasrat: "I believe we do, but you wouldn't know for sure until you actually go through the sales. So you see whether we hav
API
rossirace9s rossirace9s 41 분 전
What happened to Breathtec Biomedical?
BLOZF
The ELTP King The ELTP King 42 분 전
Nasrat said we're good for QUOTE "at least the next 5 years".

Who the hell knows for sure though...

With all these approvals & launches, how long do you think it will be before Elite is at full capacity with the new facility ???????
ELTP
The ELTP King The ELTP King 44 분 전
Thanks.

Hey Thanks A Lot King,

IB_🤴
ELTP
The ELTP King The ELTP King 45 분 전
Nasrat: "Our primary goal is to uplist to Nasdaq."

The King: "We need to uplist to Nasdaq."

LMAO! It's the SAME opinion.

I trust Nasrat's opinion on that topic much more than yours
ELTP
Walter4 Walter4 45 분 전
Sure it can go lower, same was said about one of his other companies. What is that companies share value now today when factoring in the massive reverse split? Jakes word means nothing, his actions tell all. With the way that Jake has these "companies" rigged through the 3a10 his shareholders lose e
BCAP
Humbert Humbert 46 분 전
Someone here said it was 1.1 billion, which I'll go by. The company should confirm this.

Either way, those multiples are a little low given the other conditions here.
BNCM
rossirace9s rossirace9s 47 분 전

That's a nasty 5 year chart. This is heading to all time lows. Every pump sold off. I can't believe you're still here guys. Where's AMG from the first pumps?
BLOZF
santafe2 santafe2 57 분 전
I'm not a big fan of fact-free commentary. I do still set you off now and then. I don't mean to but I do like Porter. I'd rather have Porter than Padilla. Porter and Schiff, I'd vote Schiff. He reminds me of Raskin here in MD. Just special politicians.
JJ8 JJ8 57 분 전
Pltr share price had a Bullish Triangle Breakout on 22-Nov-2024. GLTA
PLTR

최근 히스토리

EU
PRX
Prosus NV
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유